WallStreetZenWallStreetZen

NYSEMKT: VTAK
Catheter Precision Inc Stock

$0.49+0.00 (+0%)
Updated Mar 28, 2024
VTAK Price
$0.49
Fair Value Price
N/A
Market Cap
$3.41M
52 Week Low
$0.34
52 Week High
$1.70
P/E
-0.02x
P/B
0.16x
P/S
9.63x
PEG
N/A
Dividend Yield
N/A
Revenue
$314.00k
Earnings
-$78.06M
Gross Margin
92.7%
Operating Margin
-24,859.55%
Profit Margin
-25,115.3%
Debt to Equity
0.5
Operating Cash Flow
-$22M
Beta
0.73
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

VTAK Overview

Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how VTAK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

VTAK is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VTAK is good value based on its book value relative to its share price (0.16x), compared to the US Medical Devices industry average (4.11x)
P/B vs Industry Valuation
VTAK is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more VTAK due diligence checks available for Premium users.

Be the first to know about important VTAK news, forecast changes, insider trades & much more!

VTAK News

Valuation

VTAK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.02x
Industry
29.92x
Market
44.51x

VTAK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.16x
Industry
4.11x
VTAK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

VTAK's financial health

Profit margin

Revenue
$133.0k
Net Income
-$1.9M
Profit Margin
-1,448.9%
VTAK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
VTAK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$32.9M
Liabilities
$11.0M
Debt to equity
0.5
VTAK's short-term assets ($5.78M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VTAK's long-term liabilities ($8.97M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VTAK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VTAK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.8M
Investing
-$1.0k
Financing
$0.0
VTAK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

VTAK vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
VTAK$3.41M-0.82%-0.02x0.16x
VERO$3.82M-4.03%-0.10x-0.29x
INVO$2.80M+2.73%-0.09x7.50x
AEMD$4.40M-1.75%-0.33x0.58x
NUWE$2.42M-9.64%-0.03x0.81x

Catheter Precision Stock FAQ

What is Catheter Precision's quote symbol?

(NYSEMKT: VTAK) Catheter Precision trades on the NYSEMKT under the ticker symbol VTAK. Catheter Precision stock quotes can also be displayed as NYSEMKT: VTAK.

If you're new to stock investing, here's how to buy Catheter Precision stock.

What is the 52 week high and low for Catheter Precision (NYSEMKT: VTAK)?

(NYSEMKT: VTAK) Catheter Precision's 52-week high was $1.70, and its 52-week low was $0.34. It is currently -71.41% from its 52-week high and 42.94% from its 52-week low.

How much is Catheter Precision stock worth today?

(NYSEMKT: VTAK) Catheter Precision currently has 7,026,678 outstanding shares. With Catheter Precision stock trading at $0.49 per share, the total value of Catheter Precision stock (market capitalization) is $3.41M.

Catheter Precision stock was originally listed at a price of $25,000.00 in Sep 27, 2018. If you had invested in Catheter Precision stock at $25,000.00, your return over the last 5 years would have been -100%, for an annualized return of -88.58% (not including any dividends or dividend reinvestments).

How much is Catheter Precision's stock price per share?

(NYSEMKT: VTAK) Catheter Precision stock price per share is $0.49 today (as of Mar 28, 2024).

What is Catheter Precision's Market Cap?

(NYSEMKT: VTAK) Catheter Precision's market cap is $3.41M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Catheter Precision's market cap is calculated by multiplying VTAK's current stock price of $0.49 by VTAK's total outstanding shares of 7,026,678.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.